Pulmonary vascular disease & thromboembolismMeta-analysis

Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism

JACC Cardiovasc IntervPublished

  • Systematic review and meta-analysis of randomised and observational studies

Authors' conclusion

In patients with acute PE, when compared with AC alone, CDT was associated with a lower mortality but higher risk of bleeding. Moreover, CDT had an enhanced safety profile when compared with ST.

Study context

Population
Patients with acute PE
Participants
81,705 patients · 45 studies
Comparison
Anticoagulation (AC) alone vs catheter-directed thrombolysis (CDT) vs systemic thrombolysis (ST)
Outcome
All-cause mortality

Pooled result

As reported in the abstract

Odds ratio (95% CI)
CDT vs AC
0.55(0.39–0.80)
ST vs CDT
2.05(1.46–2.89)

Further pooled results

Intermediate-risk PE trials (subgroup)

Findings similar when restricted to trials of intermediate-risk PE

Safety

OutcomeOR (95% CI)
Major bleeding — CDT vs AC1.84 (1.10–3.08)
Major bleeding — ST vs AC2.16 (1.38–3.38)
Intracranial hemorrhage — CDT vs AC · numerically higher1.51 (0.75–3.04)
Intracranial hemorrhage — ST vs AC2.26 (1.14–4.48)
Intracranial hemorrhage — ST vs CDT1.50 (1.13–1.99)

Original publication

Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism. JACC Cardiovasc Interv. Published 18 October 2023. doi:10.1016/j.jcin.2023.07.042

Summarised from the published abstract; every number is checked against it